• Acne
  • Actinic Keratosis
  • Aesthetics
  • Alopecia
  • Atopic Dermatitis
  • Buy-and-Bill
  • COVID-19
  • Case-Based Roundtable
  • Chronic Hand Eczema
  • Drug Watch
  • Eczema
  • General Dermatology
  • Hidradenitis Suppurativa
  • Melasma
  • NP and PA
  • Pediatric Dermatology
  • Pigmentary Disorders
  • Practice Management
  • Precision Medicine and Biologics
  • Prurigo Nodularis
  • Psoriasis
  • Psoriatic Arthritis
  • Rare Disease
  • Rosacea
  • Skin Cancer
  • Vitiligo
  • Wound Care

News

Article

Daily Derm Times: March 21, 2025

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Daily Derm Times logo

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.

Anticipated Changes in Estate Planning for 2025 What Dermatologists Need to Know

Key estate planning changes in 2025: potential tax law shifts, federal exemption sunset, retirement account rules, state death taxes, and cryptocurrency issues.

Photosensitizing Drugs, Estrogen, and Diuretics Linked to Increased Skin Cancer Risk

Estrogen therapy and certain diuretics may increase skin cancer risk, highlighting the need for careful patient counseling and sun exposure management.

730-nm Picosecond Laser Is More Effective Than 1064-nm for Acquired Dermal Melanocytosis

The 730-nm picosecond laser had an efficacy rate of 88% with higher patient satisfaction compared to the 1604-nm wavelength.

Advancing Hidradenitis Suppurativa Care - Early Diagnosis, Biologic Therapies, and Multidisciplinary Approaches: Part 2

In part 2 of this Frontline Forum supplement, experts discuss current and emerging treatments, digital tools and supports, and more.

Supporting Reentrants: A Medical Student Volunteer Initiative

Participants reported increased confidence in clinical interactions and greater interest in dermatology as a career path.

Ritlecitinib Demonstrates Effectiveness in Subgroup Analysis of Asian Patients

At week 24, the proportion of Asian patients achieving significant hair regrowth (SALT ≤20) was substantially higher in ritlecitinib treatment groups than in placebo groups.

Q&A: How the PWRS Program and Inaugural Report is Empowering Women and Transforming Global Healthcare

Eve Arnera and Thandiwe Munaiwa, MD, spoke about the groundbreaking collaboration between SkinCeuticals and ReSurge International, “Pioneering Women in Reconstructive Surgery.”

© 2025 MJH Life Sciences

All rights reserved.